SCHEMBL30936701

SCHEMBL30936701

CNC1(Cc2ccccc2)C=CC=CC1N

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAOA P21397 7/20 0.33
MAOB P27338 7/20 0.33
CYP3A4 P08684 4/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPT P10636 3/20 0.32
KDM1A O60341 4/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 2/20 0.32
OPRM1 P35372 1/20 0.31
OPRL1 P41146 1/20 0.31
ALOX15 P16050 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
TSHR P16473 1/20 0.31
ATM Q13315 1/20 0.31
TAAR1 Q96RJ0 1/20 0.31
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5790163 0.75 MAOA (0.38) MEN1KMT2AMAOAMAOBCYP3A4
SCHEMBL394270 0.73 MAOA (0.41) MAOAMAOBCYP3A4KDM1ATSHR
SCHEMBL31294910 0.72 MAOA (0.37) MEN1KMT2AMAOAMAOBCYP3A4
SCHEMBL20699480 0.72 SLC6A2 (0.34) MEN1KMT2AMAOAMAOBCYP3A4
SCHEMBL30668471 0.67 KDM1A (0.30) KDM1A
SCHEMBL3476384 0.67 HSD11B1 (0.33) MAOAMAOBCYP3A4MAPTKDM1A
SCHEMBL30311609 0.65 MAOA (0.36) MAOAMAOBKDM1A
SCHEMBL30668455 0.64 OPRM1 (0.31) KDM1AOPRM1OPRL1
SCHEMBL605319 0.64 MAOA (0.34) MEN1KMT2AMAOAMAOBCYP3A4
SCHEMBL4304141 0.64 ALDH1A1 (0.35) MEN1KMT2AMAOAMAOBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed